SI-BONE's Participation in Morgan Stanley Global Healthcare Conference
![SI-BONE's Participation in Morgan Stanley Global Healthcare Conference](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
SI-BONE to Present at the Morgan Stanley Global Healthcare Conference
SANTA CLARA, Calif. — SI-BONE, Inc. (Nasdaq: SIBN), a leading medical device company specializing in sacropelvic disorders, has announced its participation in the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference. Management is set to host a fireside chat at this prestigious event.
Details of the Event
The conference will take place on a specific date at 10:45 a.m. Eastern Time / 7:45 a.m. Pacific Time. This platform provides SI-BONE an excellent opportunity to connect with investors and discuss the latest advancements in their product offerings, as well as developments in the treatment of sacropelvic disorders.
About SI-BONE, Inc.
SI-BONE, Inc. (NASDAQ: SIBN) has solidified its reputation as a pioneer in developing innovative technologies aimed at the surgical treatment of sacropelvic disorders. The company initiated the journey of minimally invasive sacroiliac joint surgery in 2009 and has since provided significant support to over 3,900 physicians in performing more than 100,000 surgical procedures.
Clinical Evidence and Innovations
A robust body of clinical evidence underscores the effectiveness of SI-BONE’s technologies. This evidence includes two randomized controlled trials and over 130 peer-reviewed publications, enhancing the company's credibility within the medical community. SI-BONE has skillfully utilized its expertise in minimally invasive techniques to create novel solutions addressing various adjacent markets, such as adult deformity corrections, spinopelvic fixation, and pelvic trauma.
Company’s Commitment to Innovation
SI-BONE remains committed to enhancing patient outcomes and expanding its product portfolio. The company actively seeks to address complex medical needs, ensuring that healthcare providers have access to innovative tools designed to improve surgical effectiveness and efficiency. This commitment positions SI-BONE at the forefront of orthopedic technology.
Future Prospects and Growth
The company's ongoing research and development efforts aim to further establish its market leadership. With a focus on advancing minimally invasive surgical techniques, SI-BONE continues to explore new product opportunities that could expand its influence in therapeutic areas connected to sacropelvic disorders.
Investor Relations
For potential investors and stakeholders seeking more comprehensive insights into SI-BONE, the company's dedicated investor relations team is available to provide further information regarding their products, services, and corporate strategies.
Contact Information
For inquiries, you may contact Saqib Iqbal via email at investors@si-bone.com. The company is always looking to maintain transparent communication with its investors and the healthcare community.
Frequently Asked Questions
What is the focus of SI-BONE, Inc.?
SI-BONE, Inc. specializes in the development of surgical technologies for treating sacropelvic disorders.
When is SI-BONE's session at the Morgan Stanley conference?
The specific date and time for SI-BONE's fireside chat are set for 10:45 a.m. Eastern Time.
How many procedures has SI-BONE supported?
SI-BONE has supported over 3,900 physicians in performing more than 100,000 surgical procedures.
What clinical evidence backs SI-BONE’s technologies?
SI-BONE has two randomized controlled trials and over 130 peer-reviewed publications that support the effectiveness of its technologies.
How can investors learn more about SI-BONE?
Investors can reach out to the investor relations team via email or visit the company’s website for more detailed information.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- QuantaSing Group to Announce 2024 Financial Results Soon
- Understanding Drawing Rates for Bonds by Realkredit Danmark
- Eckoh Plc Public Dealing Disclosure Overview
- Svitzer Group Notifies Board Transactions in Share Market
- OKX Wallet Integrates with NovaSeeds for IDOs
- Novaturas Reports 2024 Half-Year Financial Performance
- Cylindrical Li-ion Battery Market Growth Insights
- Ethyl Tertiary-Butyl Ether Market Trends and Growth Insights
- Northern 2 VCT PLC Director Dealings Update
- Jyske Realkredit Bond Drawings Announcement